annual D&A:
$96.43M-$7.96M(-7.63%)Summary
- As of today (July 1, 2025), BMRN annual depreciation & amortization is $96.43 million, with the most recent change of -$7.96 million (-7.63%) on December 31, 2024.
- During the last 3 years, BMRN annual D&A has fallen by -$11.61 million (-10.75%).
- BMRN annual D&A is now -10.75% below its all-time high of $108.04 million, reached on December 31, 2021.
Performance
BMRN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$22.07M-$1.54M(-6.52%)Summary
- As of today (July 1, 2025), BMRN quarterly depreciation & amortization is $22.07 million, with the most recent change of -$1.54 million (-6.52%) on March 31, 2025.
- Over the past year, BMRN quarterly D&A has dropped by -$5.28 million (-19.31%).
- BMRN quarterly D&A is now -28.21% below its all-time high of $30.74 million, reached on September 30, 2019.
Performance
BMRN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$91.14M-$5.28M(-5.48%)Summary
- As of today (July 1, 2025), BMRN TTM depreciation & amortization is $91.14 million, with the most recent change of -$5.28 million (-5.48%) on March 31, 2025.
- Over the past year, BMRN TTM D&A has dropped by -$14.17 million (-13.45%).
- BMRN TTM D&A is now -16.69% below its all-time high of $109.41 million, reached on September 30, 2021.
Performance
BMRN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BMRN Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -7.6% | -19.3% | -13.4% |
3 y3 years | -10.8% | -19.3% | -15.1% |
5 y5 years | -8.4% | -15.0% | -15.4% |
BMRN Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -10.8% | at low | -19.3% | +16.1% | -14.3% | at low |
5 y | 5-year | -10.8% | at low | -21.1% | +16.1% | -16.7% | at low |
alltime | all time | -10.8% | >+9999.0% | -28.2% | +1557.7% | -16.7% | +9115.9% |
BMRN Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $22.07M(-6.5%) | $91.14M(-5.5%) |
Dec 2024 | $96.43M(-7.6%) | $23.61M(+24.2%) | $96.43M(-3.3%) |
Sep 2024 | - | $19.01M(-28.2%) | $99.68M(-6.3%) |
Jun 2024 | - | $26.46M(-3.2%) | $106.36M(+1.0%) |
Mar 2024 | - | $27.35M(+1.8%) | $105.31M(+0.9%) |
Dec 2023 | $104.39M(+2.4%) | $26.86M(+4.6%) | $104.39M(+2.3%) |
Sep 2023 | - | $25.68M(+1.0%) | $102.08M(+0.9%) |
Jun 2023 | - | $25.42M(-3.8%) | $101.19M(+0.1%) |
Mar 2023 | - | $26.42M(+7.6%) | $101.05M(-0.9%) |
Dec 2022 | $101.97M(-5.6%) | $24.55M(-1.0%) | $101.97M(-1.4%) |
Sep 2022 | - | $24.80M(-1.9%) | $103.40M(-1.9%) |
Jun 2022 | - | $25.27M(-7.6%) | $105.44M(-1.8%) |
Mar 2022 | - | $27.34M(+5.2%) | $107.40M(-0.6%) |
Dec 2021 | $108.04M(+2.7%) | $25.99M(-3.2%) | $108.04M(-1.3%) |
Sep 2021 | - | $26.84M(-1.4%) | $109.41M(+0.2%) |
Jun 2021 | - | $27.23M(-2.7%) | $109.21M(+1.9%) |
Mar 2021 | - | $27.98M(+2.3%) | $107.19M(+1.9%) |
Dec 2020 | $105.17M(-0.1%) | $27.36M(+2.7%) | $105.17M(+1.5%) |
Sep 2020 | - | $26.63M(+5.6%) | $103.60M(-3.8%) |
Jun 2020 | - | $25.22M(-2.9%) | $107.71M(-1.0%) |
Mar 2020 | - | $25.96M(+0.7%) | $108.84M(+3.4%) |
Dec 2019 | $105.30M(+10.1%) | $25.79M(-16.1%) | $105.30M(+1.0%) |
Sep 2019 | - | $30.74M(+16.7%) | $104.23M(+4.4%) |
Jun 2019 | - | $26.34M(+17.5%) | $99.83M(+5.7%) |
Mar 2019 | - | $22.43M(-9.3%) | $94.47M(-1.3%) |
Dec 2018 | $95.67M(+8.9%) | $24.72M(-6.2%) | $95.67M(-4.0%) |
Sep 2018 | - | $26.34M(+25.6%) | $99.62M(+6.0%) |
Jun 2018 | - | $20.98M(-11.2%) | $93.97M(+2.1%) |
Mar 2018 | - | $23.63M(-17.6%) | $92.08M(+4.8%) |
Dec 2017 | $87.86M(-9.3%) | $28.66M(+38.5%) | $87.86M(+10.8%) |
Sep 2017 | - | $20.70M(+8.5%) | $79.30M(-9.9%) |
Jun 2017 | - | $19.09M(-1.7%) | $88.03M(-9.8%) |
Mar 2017 | - | $19.41M(-3.5%) | $97.60M(+0.7%) |
Dec 2016 | $96.91M(+105.4%) | $20.11M(-31.7%) | $96.91M(+8.1%) |
Sep 2016 | - | $29.42M(+2.7%) | $89.69M(+24.0%) |
Jun 2016 | - | $28.66M(+53.0%) | $72.31M(+31.2%) |
Mar 2016 | - | $18.73M(+45.3%) | $55.10M(+16.8%) |
Dec 2015 | $47.19M(+2.9%) | $12.89M(+7.0%) | $47.19M(+17.2%) |
Sep 2015 | - | $12.04M(+5.2%) | $40.27M(-5.2%) |
Jun 2015 | - | $11.45M(+5.8%) | $42.45M(-5.0%) |
Mar 2015 | - | $10.82M(+81.3%) | $44.68M(-2.6%) |
Dec 2014 | $45.87M(+27.4%) | $5.97M(-58.1%) | $45.87M(+19.5%) |
Sep 2014 | - | $14.22M(+4.0%) | $38.39M(+2.4%) |
Jun 2014 | - | $13.68M(+13.9%) | $37.48M(+2.2%) |
Mar 2014 | - | $12.00M(-892.9%) | $36.67M(+1.8%) |
Dec 2013 | $36.01M(-18.8%) | -$1.51M(-111.4%) | $36.01M(-25.6%) |
Sep 2013 | - | $13.31M(+3.5%) | $48.42M(+3.5%) |
Jun 2013 | - | $12.87M(+13.4%) | $46.78M(+3.8%) |
Mar 2013 | - | $11.35M(+4.1%) | $45.09M(+1.7%) |
Dec 2012 | $44.34M(+26.5%) | $10.90M(-6.6%) | $44.34M(+5.5%) |
Sep 2012 | - | $11.67M(+4.4%) | $42.02M(+5.8%) |
Jun 2012 | - | $11.17M(+5.4%) | $39.70M(+7.1%) |
Mar 2012 | - | $10.60M(+23.5%) | $37.06M(+5.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $35.05M(+26.4%) | $8.58M(-8.2%) | $35.05M(+1.9%) |
Sep 2011 | - | $9.35M(+9.6%) | $34.40M(+4.7%) |
Jun 2011 | - | $8.53M(-0.6%) | $32.87M(+6.3%) |
Mar 2011 | - | $8.59M(+8.2%) | $30.91M(+11.4%) |
Dec 2010 | $27.74M(+32.2%) | $7.93M(+1.4%) | $27.74M(+12.4%) |
Sep 2010 | - | $7.82M(+18.9%) | $24.67M(+13.7%) |
Jun 2010 | - | $6.58M(+21.6%) | $21.69M(+1.9%) |
Mar 2010 | - | $5.41M(+11.3%) | $21.28M(+1.5%) |
Dec 2009 | $20.98M(+19.1%) | $4.86M(+0.4%) | $20.98M(+0.6%) |
Sep 2009 | - | $4.84M(-21.5%) | $20.86M(-16.1%) |
Jun 2009 | - | $6.17M(+20.9%) | $24.85M(+14.6%) |
Mar 2009 | - | $5.10M(+7.6%) | $21.69M(+23.1%) |
Dec 2008 | $17.62M(+1516.1%) | $4.74M(-46.3%) | $17.62M(+35.2%) |
Sep 2008 | - | $8.84M(+193.8%) | $13.03M(+214.1%) |
Jun 2008 | - | $3.01M(+191.7%) | $4.15M(+224.6%) |
Mar 2008 | - | $1.03M(+556.7%) | $1.28M(+17.2%) |
Dec 2007 | $1.09M(-88.9%) | $157.00K(-441.3%) | $1.09M(-17.9%) |
Sep 2007 | - | -$46.00K(-133.8%) | $1.33M(-70.2%) |
Jun 2007 | - | $136.00K(-83.9%) | $4.46M(-44.9%) |
Mar 2007 | - | $843.00K(+114.0%) | $8.10M(-17.3%) |
Dec 2006 | $9.79M(+0.4%) | $394.00K(-87.2%) | $9.79M(-17.3%) |
Sep 2006 | - | $3.09M(-18.3%) | $11.85M(+5.9%) |
Jun 2006 | - | $3.78M(+49.0%) | $11.19M(+14.0%) |
Mar 2006 | - | $2.54M(+3.6%) | $9.82M(+0.7%) |
Dec 2005 | $9.75M(-26.6%) | $2.45M(+0.8%) | $9.75M(-25.4%) |
Sep 2005 | - | $2.43M(+1.0%) | $13.06M(+2.1%) |
Jun 2005 | - | $2.40M(-2.5%) | $12.79M(-5.7%) |
Mar 2005 | - | $2.47M(-57.2%) | $13.55M(+2.1%) |
Dec 2004 | $13.28M(+40.6%) | $5.76M(+167.1%) | $13.28M(+34.1%) |
Sep 2004 | - | $2.16M(-32.1%) | $9.90M(-7.3%) |
Jun 2004 | - | $3.17M(+44.8%) | $10.68M(+11.9%) |
Mar 2004 | - | $2.19M(-8.1%) | $9.55M(+1.1%) |
Dec 2003 | $9.44M(+11.0%) | $2.38M(-18.7%) | $9.44M(+5.6%) |
Sep 2003 | - | $2.93M(+43.7%) | $8.94M(+6.6%) |
Jun 2003 | - | $2.04M(-2.2%) | $8.39M(-1.6%) |
Mar 2003 | - | $2.08M(+10.7%) | $8.53M(+0.3%) |
Dec 2002 | $8.50M(+21.4%) | $1.88M(-20.9%) | $8.50M(+14.0%) |
Sep 2002 | - | $2.38M(+9.3%) | $7.46M(+2.4%) |
Jun 2002 | - | $2.18M(+5.7%) | $7.28M(+1.6%) |
Mar 2002 | - | $2.06M(+145.6%) | $7.17M(+2.3%) |
Dec 2001 | $7.00M(+22.2%) | $839.00K(-61.9%) | $7.00M(+6.8%) |
Sep 2001 | - | $2.20M(+6.8%) | $6.56M(+4.7%) |
Jun 2001 | - | $2.06M(+8.5%) | $6.26M(+6.2%) |
Mar 2001 | - | $1.90M(+381.0%) | $5.90M(+2.9%) |
Dec 2000 | $5.73M(+5.9%) | $395.00K(-79.3%) | $5.73M(-12.5%) |
Sep 2000 | - | $1.91M(+12.4%) | $6.55M(-1.4%) |
Jun 2000 | - | $1.70M(-2.1%) | $6.65M(+7.9%) |
Mar 2000 | - | $1.73M(+42.7%) | $6.16M(+13.8%) |
Dec 1999 | $5.42M(+576.9%) | $1.22M(-39.3%) | $5.42M(+28.9%) |
Sep 1999 | - | $2.00M(+65.2%) | $4.20M(+90.9%) |
Jun 1999 | - | $1.21M(+22.4%) | $2.20M(+122.4%) |
Mar 1999 | - | $989.00K | $989.00K |
Dec 1998 | $800.00K | - | - |
FAQ
- What is BioMarin Pharmaceutical annual depreciation & amortization?
- What is the all time high annual D&A for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual D&A year-on-year change?
- What is BioMarin Pharmaceutical quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly D&A year-on-year change?
- What is BioMarin Pharmaceutical TTM depreciation & amortization?
- What is the all time high TTM D&A for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM D&A year-on-year change?
What is BioMarin Pharmaceutical annual depreciation & amortization?
The current annual D&A of BMRN is $96.43M
What is the all time high annual D&A for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual depreciation & amortization is $108.04M
What is BioMarin Pharmaceutical annual D&A year-on-year change?
Over the past year, BMRN annual depreciation & amortization has changed by -$7.96M (-7.63%)
What is BioMarin Pharmaceutical quarterly depreciation & amortization?
The current quarterly D&A of BMRN is $22.07M
What is the all time high quarterly D&A for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly depreciation & amortization is $30.74M
What is BioMarin Pharmaceutical quarterly D&A year-on-year change?
Over the past year, BMRN quarterly depreciation & amortization has changed by -$5.28M (-19.31%)
What is BioMarin Pharmaceutical TTM depreciation & amortization?
The current TTM D&A of BMRN is $91.14M
What is the all time high TTM D&A for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM depreciation & amortization is $109.41M
What is BioMarin Pharmaceutical TTM D&A year-on-year change?
Over the past year, BMRN TTM depreciation & amortization has changed by -$14.17M (-13.45%)